|

Empasiprubart IV Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since July 2026

Pipeline

Phase 2: 2

Top Sponsors

  • argenx3

Indications

  • gMG3
  • AChR-Ab Seropositive Generalized Myasthenia Gravis3
  • Cancer3
  • MG2
  • Myasthenia Gravis2

Carlsbad, California2 trials

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Profound Research LLC - Carlsbad

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Profound Research LLC - Carlsbad

Phase 2

Miami, Florida1 trial

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Visionary Investigators Network

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.